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Department of Bioengineering, University of California, Riverside, CaliforniaABSTRACT Staphylococcus aureus expresses numerous virulence factors that aid in immune evasion. The four-domain
staphylococcal immunoglobulin binding (Sbi) protein interacts with complement component 3 (C3) and its thioester domain
(C3d)-containing fragments. Recent structural data suggested two possible modes of binding of Sbi domain IV (Sbi-IV) to
C3d, but the physiological binding mode remains unclear. We used a computational approach to provide insight into the
C3d-Sbi-IV interaction. Molecular dynamics (MD) simulations showed that the first binding mode (PDB code 2WY8) is more
robust than the second (PDB code 2WY7), with more persistent polar and nonpolar interactions, as well as conserved interfacial
solvent accessible surface area. Brownian dynamics and steered MD simulations revealed that the first binding mode has
faster association kinetics and maintains more stable intermolecular interactions compared to the second binding mode. In light
of available experimental and structural data, our data confirm that the first binding mode represents Sbi-IV interaction with C3d
(and C3) in a physiological context. Although the second binding mode is inherently less stable, we suggest a possible
physiological role. Both binding sites may serve as a template for structure-based design of novel complement therapeutics.INTRODUCTIONStaphylococcus aureus (S. aureus) produces numerous
toxins and virulence factors known to disrupt a wide array
of biological functions (1,2). Recent work has identified
secreted proteins that disrupt function of the complement
system (3–8), a branch of innate immunity responsible
for phagocytosis of pathogens in the bloodstream. Sbi, a
four-domain protein associated with the cell wall of
S. aureus (9), contains two domains (III and IV) that
bind complement component 3 (C3) and its thioester
domain (C3d)-containing fragments (6). C3 is the central
component of complement activation cascades, which is
cleaved to form C3a and C3b by convertase enzymes.
C3b covalently attaches to bacterial surfaces via its thio-
ester domain (C3d), which becomes solvent exposed after
C3a is cleaved from C3. Functional studies indicate that
an Sbi construct comprised only of domains III and IV
(Sbi-III/IV) leads to rapid consumption of C3 in the blood-
stream, preventing C3 from being activated to C3b and
opsonizing the bacterial surface. Interestingly, domain IV
of Sbi (Sbi-IV) on its own specifically inhibits activation
of the complement alternative pathway (AP) by preventing
active convertase formation, representing an entirely
different mechanism of action (6).
The structures of Sbi-IV, both free and in complex with
C3d, were recently reported (10). Dual binding modes were
reported for Sbi-IV, with binding observed at the concave
acidic region (Complex 1) and at the convex thioester-
containing region (Complex 2). Mutagenesis studies of
Sbi-IV binding and function, together with astounding sim-Submitted August 29, 2013, and accepted for publication January 23, 2014.
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inhibitors Efb-C and Ecb at the concave acidic region
(11,12), suggest that Complex 1 is responsible for AP inhi-
bition (10,13). Nearly all known ligands of C3d bind at or
near the concave acidic region (Fig. S1 in the Supporting
Material). This region is suggested to be evolutionarily
conserved, facilitating complement-mediated recruitment
of B cells to bacterial surfaces via interaction with comple-
ment receptor 2 (CR2) (14). The second proposed binding
site of Sbi-IV (Complex 2) represents a novel C3d interac-
tion site (Fig. S1). If Sbi-IV indeed binds to the convex
thioester-containing region, this binding mode could repre-
sent a previously uncharacterized complement evasion
tactic by pathogens. However, both the physiological sig-
nificance and existential probability of Complex 2 remain
unclear.
Macromolecular crystallography provides invaluable
insight into the structural basis of protein interactions and
how these interactions translate into functional phenomena
observed in vitro and in vivo. However, one major limitation
involves capturing molecules of interest in static conforma-
tions. Crystallization of proteins with their binding partners
may induce nonphysiological binding conformations due
to crystallization conditions and crystal packing effects.
Indeed, recent cocrystal structures involving complement
proteins suggest binding arrangements that are somewhat
contradictory (15–21). We describe herein the integration
of a variety of computational tools to analyze two recently
published crystallographic structures of C3d in complex
with Sbi-IV. We seek to evaluate the binding of Complexes
1 and 2 under simulated physiological conditions, by exam-
ining their dynamic stability and associative and dissocia-
tive properties.http://dx.doi.org/10.1016/j.bpj.2014.01.033
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Structure preparation
Three-dimensional cocrystal structures of C3d-Sbi-IV Complexes 1 (Pro-
tein Data Bank (PDB) code 2WY8) and 2 (PDB code 2WY7) were obtained
from the PDB (22). In cases where multiple crystallographic positions were
reported for given residues, position Awas selected as the residue position,
since all positions had 50% occupancy in the original PDB files.Analysis of electrostatic similarities of proteins
Analysis of electrostatic similarities of proteins (AESOP) (23–26) was used
to quantify the effects of specific charged residues on C3d-Sbi-IV associa-
tion in Complexes 1 and 2. First, PDB2PQR (27) was used to add hydrogen
atoms, partial charges, and atomic radii to each complex PDB structure,
using the PARSE force field (28). Theoretical alanine scan mutagenesis
was performed for all charged residues of the protein complexes, one at a
time. For each mutated protein and protein complex, electrostatic potential
maps and free energies were calculated using APBS (29), as described
previously (23,24,26,30). For electrostatics calculations, we used protein
and solvent dielectric values of 20 and 78.54, respectively, and ionic
strength values of 0 and 150 mM. The choice of the value of protein dielec-
tric is justified in an earlier study (25). Electrostatic similarity clustering
and calculation of electrostatic free energies of association and solvation
were performed as described previously (23,26).Explicit-solvent molecular dynamics simulations
Molecular dynamics (MD) simulations of Complexes 1 and 2 were per-
formed using NAMD (31). PDB structures of each complex were prepared
using the PSFGEN utility in VMD (32) and the CHARMM27 force field
(33). Complexes 1 and 2 were solvated in TIP3P water boxes measuring
87 A˚  87 A˚  87 A˚ and 82 A˚  82 A˚  82 A˚, respectively. Sodium
and chloride counterions were added to neutralize the charge of each
system, with an ionic strength of 150 mM. Each system was minimized
using 25,000 steps of conjugate gradient energy minimization, followed
by heating from 0 to 300 K (62 ps total), four equilibration stages (50 ps
each) with all protein atoms harmonically constrained (using force con-
stants of 10, 5, 2, and 1 kcal/mol/A˚2, respectively) to their postminimization
positions, and a final equilibration stage (50 ps) with protein backbone
atoms harmonically constrained (using a force constant of 1 kcal/mol/A˚2),
followed by the production run. All simulations were performed using
periodic boundary conditions and particle-mesh Ewald electrostatics with
a nonbonded interaction cutoff and switching distance of 12 A˚ and 10 A˚,
respectively. The SHAKE algorithm was employed to fix the length of
bonds involving hydrogen atoms, enabling the use of 2 fs integration
time steps. Langevin temperature and pressure controls were used for all
NPT ensemble simulations. For each system, one 100 ns trajectory and
three 20 ns trajectories were performed, using the energy-minimized co-
ordinates of each system as the starting point for all simulations, with
different random-number-generated seeds.Steered MD simulations
Steered MD (SMD) simulations were also performed using NAMD. For
each system, the solvent accessible surface of C3d atoms within 8 A˚ of
Sbi-IV and its normal vectors were calculated using the UCSF Chimera
(34). The mean of the normal vectors was used as the direction of induced
Sbi-IV dissociation from C3d. To facilitate SMD simulations and analysis,
each complex was rotated such that the mean normal vector was aligned
with the þz axis. Complexes 1 and 2 were solvated in TIP3P water boxes
measuring 76 A˚  87 A˚  105 A˚ and 75 A˚  78 A˚  104 A˚, respectively,
which provided additional space for Sbi-IV dissociation in theþz direction.Each system was minimized and heated as described above, followed by a
500 ps equilibration stage with all protein atoms harmonically restrained us-
ing a force constant of 10 kcal/mol/A˚2. Equilibrated structures were used as
input for all SMD simulations. Five 1.6 ns SMD simulations were per-
formed for each complex. Residues of C3d >12 A˚ from Sbi-IV were
harmonically constrained to their equilibrated positions during the SMD
simulations with a force constant of 10 kcal/mol/A˚2. The center of mass
of all Sbi-IV atoms was constrained (with a force constant of 10 kcal/
mol/A˚2) to a point moving at a constant velocity of 10 A˚/ns in the þz
direction.Brownian dynamics simulations
Brownian dynamics (BD) simulations for Complexes 1 and 2 were per-
formed using BrownDye (35). For each complex, PQR files and electro-
static potential maps were generated for C3d and Sbi-IV as described
above. In all simulations, C3d was the stationary molecule and Sbi-IV
was the diffusing molecule. Reaction criteria were selected based on a pilot
comparative study using mutants of barnase-barstar and corresponding
experimental kon data (data not shown). Pairwise residue interactions
were calculated from energy-minimized structures of each complex, using
cutoff distances of either 3.5 A˚ or 5.0 A˚. Successful reactions in BD simu-
lations required formation of at least two (or three) interactions from the
pairwise list, with interatomic distance <6.0 (or 6.5) A˚. The program
bd_top was used to generate all necessary input files for BD simulations,
and 100,000 trajectories were performed for each system under each set
of reaction conditions. Reaction probabilities and corresponding kon rates
were calculated by BrownDye.MD simulation analysis
MD trajectories were analyzed using the Bio3D package (36) and
additional custom scripts in R. Analysis of hydrogen bonds and visual
PDB and MD trajectory analysis were performed with UCSF Chimera.
Solvent accessible surface area (SASA) for proteins and protein complexes
was determined using VMD, and interfacial SASA was calculated
according to
DSASA ¼ SASAAB  SASAA  SASAB; (1)
where SASAAB, SASAA, and SASAB are the SASAs of the protein complex
and free proteins, respectively. All SASA calculations were performed on
MD snapshots with all hydrogen atoms present. Association free energies
were calculated using the molecular mechanics/generalized Born surface
area (MM-GBSA) method, based on snapshots from one 100 ns and three
20 ns trajectories for each protein complex. The first 10 ns of each simu-
lation were not used in calculating MM-GBSA free energies. Free-energy
values were calculated according to
DG ¼ GAB  GA  GB; (2)
where GAB, GA, and GB are the free energies of the protein complex (C3d-
Sbi-IV) and free components (C3d and Sbi-IV), respectively. Free energy(G) is calculated according to
Gi ¼ EMM  Gsolv  TDS; (3)
whereEMM ¼ Ebonded þ Evdw þ ECoul; (4)
and
Gsolv ¼ Gelec þ Gnp: (5)Biophysical Journal 106(5) 1164–1173
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only, so conformational changes between free and bound C3d and/or Sbi-IV
are neglected. Thus, in calculating DG, Ebonded terms cancel, leaving
DG ¼ DEvdw þ DECoul þ DGelec þ DGnp: (6)
The first and second terms on the righthand side of Eq. 6 were obtained us-
ing CHARMM and the CHARMM27 force field. The third term represents
the Generalized Born approximation of solvation free energy, and it was
calculated using the GBSW module in CHARMM. The final term repre-
sents the nonpolar contribution to solvation energy, calculated according to
DGnp ¼ g  DSASA; (7)
where g is the surface-tension parameter, set to 0.005 kcal/mol/A˚2. Per-res-
idue MM-GBSA free energies were calculated in the same manner, but
using a residue-protein rather than protein-protein interaction. Reported
values for electrostatic free energy are comprised of the sum of the second
and third righthand terms in Eq. 6, and the nonpolar free-energy values
are comprised of the sum of the first and fourth terms. Total energy refers
to the DG quantity described in Eq. 6. Mean energies were calculated for
snapshots within each trajectory. The reported energy values reflect the
mean 5 SD across the four trajectories for each complex.FIGURE 1 Molecular graphics representations of C3d-Sbi-IV com-
plexes. (A) The two binding modes of Sbi-IV (orange and cyan) are shown
bound to C3d (purple). (B and C) Open-book representations of C3d-Sbi-IV
Complex 1 (B) and Complex 2 (C), illustrating electrostatic complemen-
tarity at each interface. C3d and Sbi-IV are rotated about the horizontal
axis (black line) by 90 and þ90, respectively. Molecular surfaces
are colored based on electrostatic potential values, with a gradient from
5 kBT/e (red) to þ5 kBT/e (blue). To see this figure in color, go online.RESULTS
Electrostatic analysis
Sbi-IV is a three-helix bundle that exhibits binding to C3d
via the acidic concave region (Complex 1) and the convex
thioester-containing region (Complex 2) according to the
crystallographic structures (10). Fig. 1 A shows a compari-
son of both binding modes, with the Sbi-IV molecule
from Complexes 1 and 2 on the left and right sides, respec-
tively, of C3d. The interfacial SASA is similar for the two
complexes (1901 A˚2 and 1671 A˚2, respectively). There is
electrostatic complementarity at both binding interfaces,
but the complementarity is much more pronounced in
Complex 1 (Fig. 1, B and C). To quantify the role of electro-
statics in C3d-Sbi-IV association at each binding site, we
performed AESOP analyses. Based on the magnitudes and
perturbations of electrostatic free energies upon mutation
of ionizable residues to alanine, it is clear that Complex 1
(Fig. 2 A and C) is much more electrostatically driven
than Complex 2 (Fig. 2 B and D). There are six C3d muta-
tions and seven Sbi-IV mutations that experience>5 kJ/mol
gain in association free energy in Complex 1, whereas in
Complex 2, no C3d mutations and only two Sbi-IV muta-
tions result in considerable changes in energy. These data
reflect that the Complex 1 interface is significantly more po-
lar than the Complex 2 interface.MD simulations
We used explicit-solvent MD simulations to examine the dy-
namic stability of Complex 1 and 2 binding modes (Movie
S1). Data from a previous study suggest that Complex 1 is
the primary binding mode for C3d-Sbi-IV (10). Fig. 3 shows
the conformational changes of each complex over the courseBiophysical Journal 106(5) 1164–1173of 100 ns of MD simulation. Superposition of C3d at five
representative snapshots (0, 25, 50, 75, and 100 ns) indicates
a stable interaction between C3d and Sbi-IV in the Complex
1 binding mode (Fig. 3 A), with only slight fluctuations
observed at the N- and C termini of Sbi-IV. In contrast,
we observe larger fluctuations in the Sbi-IV structure
when bound to C3d in the Complex 2 binding mode
(Fig. 3 B), particularly at the N-terminus, which seems to
remain only transiently bound to C3d. We quantified these
dynamic fluctuations through root mean-square fluctuation
(RMSF) calculations for Sbi-IV residues from Complex 1
and Complex 2 (Fig. S2). With the exception of a small
number of residues in helix 3, the RMSF of Sbi-IV residues
in Complex 2 is higher than that of Sbi-IV residues in
Complex 1. Sbi-IV residues near the N- and C-termini in
Complex 2 have significantly higher fluctuation, which sug-
gests that these residues do not contribute significantly to
C3d binding. Closer examination of the MD snapshots re-
veals that in Complex 1, C3d-Sbi-IV binding is dominated
by a central core of interacting residues, supplemented by
alternating peripheral interacting residues near the N- and
C termini. In concordance with the AESOP electrostatic
analysis, we observe that the interface is dominated by
salt bridges and hydrogen bonds involving basic Sbi-IV
residues (R206, R231, R235, K239, and K245), but is also
FIGURE 2 Electrostatic free energies of C3d-Sbi-IVassociation. Free energies were calculated using a thermodynamic cycle including protein association
and solvation, and Poisson-Boltzmann electrostatics calculations, for C3d from Complex 1 (A), C3d from Complex 2 (B), Sbi-IV from Complex 1 (C),
and Sbi-IV from Complex 2 (D). Residue labels refer to the corresponding alanine mutations, and magnitudes refer to calculated energies relative to the
wild-type complex. Only ionizable residues are included. The underlined residues on the x axis indicate mutations that are most unfavorable to complex
binding.
C3d-Sbi Interaction Analysis 1167reinforced by nonpolar residues present on all three helices
(Fig. S3 A and Table S1). In Complex 2, the N-terminus
of Sbi-IV helix 1 is only transiently bound to C3d, and
thus the interface is stabilized primarily by a localized
core of hydrogen bonds and nonpolar interactions at the
C-terminus of helix 1 and the N-terminus of helix 3
(Fig. S3 B and Table S1).
Since Complex 2 is largely stabilized by nonpolar interac-
tions, we measured the interfacial SASA of both complexes
over the course of all MD trajectories, to compare the stabil-
ity of the observed crystallographic interfaces. We observe
that in general, interfacial SASA of Complex 1 remains con-
stant over time, whereas Complex 2 undergoes significantloss of interfacial SASA (Fig. 4). Despite these data, we
did not observe complete dissociation of Complex 2 at
any point, and the interfacial SASA tends to reach a steady
state within ~10 ns in all trajectories. In addition, observed
losses in interfacial SASAwere not always permanent. Near
the end of the 100 ns MD trajectory for Complex 2, we
observed a sudden increase in interfacial SASA (Fig. 4 B).
Examination of this trajectory revealed unwinding of the
N-terminus of Sbi-IV helix 1, which facilitated formation
of charge-charge interactions that guided the N-terminus
back to C3d (see Fig. 3 B).
Weakening of Complex 2 (relative to the crystallographic
structure) can be also observed through the number ofBiophysical Journal 106(5) 1164–1173
FIGURE 3 MD snapshots from 100 ns trajectories of C3d-Sbi-IV complexes. Upper left snapshots (black outline) show superpositions of C3d-Sbi-IV
complexes of Complex 1 (A) and Complex 2 (B). The N- and C-termini of Sbi-IV are labeled NT and CT. Five snapshots at timepoints 0, 25, 50, 75,
and 100 ns, as labeled in clockwise sequence (black arrows), are shown for each complex. Residues forming hydrogen bonds in each snapshot are shown
(short blue lines). To see this figure in color, go online.
1168 Gorham et al.nonpolar interactions, hydrogen bonds, and salt bridges
throughout MD trajectories (Figs. S4–S6). Furthermore,
although the two complexes are stabilized by comparable
numbers of nonpolar interactions (Fig. 5, A and B), polar in-
teractions are much more dominant at the Complex 1 inter-
face (Fig. 5, C–F). In the initial configuration of Complex 2,Biophysical Journal 106(5) 1164–1173there is a relative physicochemical mismatch between
residues at the N-terminus of Sbi-IV and the N-terminal
loops and helices of C3d. N-terminal Sbi-IV residues pre-
ferentially engage in intramolecular interactions, including
salt bridges and a hydrophobic cluster. As a consequence,
N-terminal residues 198–203 of Sbi-IV tend to move
AB
FIGURE 4 Change in interfacial SASA during MD trajectories of C3d-
Sbi-IV complexes. Interfacial SASA versus time for three independent
20 ns (A) and 100 ns (B) MD trajectories of Complexes 1 (dark gray)
and 2 (light gray). Data points in A represent the mean5 SE of interfacial
SASA.
C3d-Sbi Interaction Analysis 1169away from C3d, whereas nonpolar interactions in the
C-terminal region of helix 1 and the N-terminal region of
helix 3 hold the complex together (Fig. 5 B and Fig.S3 B).
In contrast, intermolecular interactions are well conserved
throughout the MD trajectories for Complex 1. The Sbi-
IV N-terminus is less prone to dynamic instability; Arg
and Lys residues (K202, R206, and R210) switch between
stabilizing helix 1 of Sbi-IV and forming salt-bridging
interactions with C3d residues. Notably, Sbi-IV residues
responsible for interaction with C3d in Complex 1 are
more dispersed, consisting of positively charged residues
in the N-terminal region of helix 1, all of helix 2, and the
N- and C-terminal regions of helix 3 (Fig. 5, A, C, and E,
and Fig. S3 A).
MM-GBSA calculations provide further quantitative
insight into the energetic nature of Complexes 1 and 2.
Overall, Complex 1 is enthalpically favored over Complex
2, in terms of both electrostatic and nonpolar interactions
(Fig. 6 A). The importance of electrostatic interactions
in Complex 1 is again evident here, as electrostatic inter-
actions account for ~33% of the total free energy (compared
to ~19% for Complex 2). Examination of per-residue freeenergy contributions reveals that the majority (14 of 20)
of interacting residues in Complex 1 are charged (Fig. 6
B). Sbi-IV residues that contribute to the free energy of
Complex 2 primarily interact via nonpolar interactions and
hydrogen bonds (most charged Sbi-IV residues in Fig. 6 C
interact via hydrogen bonds, not salt bridges). A large num-
ber of residues (from both C3d and Sbi-IV) contribute
to binding of Complex 1. As discussed earlier, Complex 1
is stabilized by a central core of interactions, primarily
involving electrostatic interactions between Sbi-IV helix 2
(residues 227–239) and acidic residues surrounding the
concave surface of C3d. A number of residues from helix
1, and to a lesser extent from helix 3, form energetically
favorable contacts as well, resulting in a dispersed network
of interactions (Fig. S7 A). In Complex 2, fewer Sbi-IV
residues make energetically favorable contacts with C3d,
and these contribute less significantly to the free energy of
C3d-Sbi-IV complex formation (Fig. 6 C). Furthermore,
these residues are localized and not distributed well among
Sbi-IV helices, compared to Complex 1 (Fig. S7 B).BD simulations
Since equilibrium binding of protein complexes is com-
prised of association and dissociation phases, we used
computational tools to probe each of these phases. BD sim-
ulations show that Complex 1 associates more than an order
of magnitude faster than Complex 2 (Fig. 7). To verify that
these data were not dependent on selected reaction criteria,
we first calculated kon values for mutants of barnase-barstar
via BD simulations, using a diverse set of reaction criteria.
We compared our results to experimental kon data for bar-
nase-barstar and identified reaction criteria that yielded
the closest agreement between calculated and experimental
data (37). Although BD simulations accurately depict
electrostatically driven diffusion, there are inherent limita-
tions in such simulations. BD simulations are necessarily
rigid-body simulations, in which each binding partner re-
mains in its static (bound) conformation. This assumption
is adequate for long-range encounter complex formation.
Once proteins encounter each other, in a near-native orien-
tation, successful binding is almost inevitable, since residue
side chains are locked in their binding configurations
(Movie S2). Thus, the difference in association rates be-
tween Complexes 1 and 2 may be larger, especially since
our MD data suggest that interactions observed from the
crystal structure of Complex 2 may be inadvertently
strengthened by crystal packing effects.SMD simulations
To examine the dissociation phase of C3d-Sbi-IV inter-
actions, we induced unbinding using SMD simulations
(38,39). In each simulation, the center of mass of Sbi-IV
was pulled away from C3d at a constant velocity, and theBiophysical Journal 106(5) 1164–1173
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FIGURE 5 Interaction occupancy during MD
trajectories of C3d-Sbi-IV complexes. Interactions
were calculated at 100 ps intervals throughout
one 100 ns and three 20 ns MD trajectories for
Complexes 1 and 2. Occupancies represent the per-
centage of snapshots (across all trajectories) in
which specific interactions were present. Residue
numbers on the x and y axes represent residues of
Sbi-IV and C3d, respectively. The legend shows
the color scale from white (0% occupancy) to pur-
ple (100% occupancy). Interactions calculated
include nonpolar interactions for Complex 1 (A)
and Complex 2 (B), hydrogen bonds for Complex
1 (C) and Complex 2 (D), and salt bridges for
Complex 1 (E) and Complex 2 (F). The residue
ranges for Sbi-IV helices are indicated on the right.
To see this figure in color, go online.
1170 Gorham et al.force acting on Sbi-IV was calculated throughout the trajec-
tories (Movie S3). The force required to pull Sbi-IV from
C3d is approximately twofold larger for Complex 1 than
for Complex 2, indicating that the latter interaction is less
stable. This result is confirmed in multiple SMD trajectories
(Fig. 8). In addition, by examining the number of intermo-
lecular interactions over time, we observe that loss of inter-
action occurs gradually (Figs. S8–S10), which may explain
the gentle slope of the force curves after the critical force is
reached (see Movie S3, for example). It should be noted that
Sbi-IV did not always dissociate from C3d in the same
manner. Movie S3 shows the most representative trajec-
tories for Complex 1 and 2 SMD simulations. In Complex
1, Sbi-IV dissociates nearly uniformly, with the N- and
C-terminal regions dissociating first and helix 2 (with the
strongest interacting residues) dissociating last (Fig. S11,
A, B, and E). All of the force-time plots show a steady
rise up to the critical force, followed by a gradual loss of
force to near zero. The strength of C3d-Sbi-IV interactions
is echoed in another SMD trajectory, in which Sbi-IVBiophysical Journal 106(5) 1164–1173does not dissociate, but rather, helix 1 is pulled away from
the rest of Sbi-IV (Fig. S11 D). Thus, intramolecular Sbi-
IV interactions are preferentially disrupted over intermolec-
ular C3d-Sbi-IV interactions. In Complex 2, on the other
hand, dissociation was less uniform. In two SMD trajec-
tories, Sbi-IV dissociated termini first, followed by helix
3, and finally by the C-terminus of helix 1 (Movie S3 and
Fig. S11, F and H). In the remaining trajectories, the Sbi-
IV N-terminus dissociated last, which may be influenced
by the initial position of this region from the crystallo-
graphic structure (Fig. S11, G, I, and J). In contrast to the
force-time plots for Complex 1 SMD trajectories, Complex
2 trajectories exhibit less well-defined force increase and
decrease, likely due to less energetically favorable contacts
(in both quantity and magnitude).DISCUSSION
We have implemented a computational framework
comprised of electrostatic free energy calculations, MD
A C
B
FIGURE 6 MM-GBSA free energies of C3d-Sbi-IV complexes. (A) Electrostatic, nonpolar, and total MM-GBSA association free energies for Complexes
1 and 2. (B and C) Per-residue MM-GBSA free energies for C3d and Sbi-IV are shown for Complexes 1 (B) and 2 (C).
C3d-Sbi Interaction Analysis 1171simulations and MM-GBSA free energy calculations, and
BD, and SMD simulations to shed light on the binding
mode between staphylococcal virulence factor Sbi and
complement fragment C3d. In accordance with extensive
biophysical analyses for the C3d-Sbi-IV interaction (10),
our data suggest that Sbi-IV likely binds via the mode
observed in Complex 1. Complex 1 is stabilized by
numerous polar and nonpolar interactions over a large
area, most of which are conserved throughout MD trajec-FIGURE 7 Comparison of association rates of C3d-Sbi-IV complexes.
Rates were calculated by Brownian dynamics simulations under four con-
ditions, with varied BD parameters including the cutoff distance for listing
candidate atomic contact pairs (List Distance), the distance required for
successful atomic contact (Contact Distance), and the number of atomic
contacts (Number of Contacts). Dark gray and light gray bars represent
calculated kon values (with 95% confidence intervals) for Complexes 1
and 2, respectively.tories and are energetically favorable. In addition, the inter-
facial SASA of Complex 1 remains constant. In contrast,
there is significant loss of interfacial SASA for Complex
2; the N-terminus of Sbi-IV tends to move away from
C3d, whereas the C-terminus of helix 1 and the N-terminus
of helix 3 hold the complex together, primarily via nonpolar
interactions. BD and SMD simulations illustrate that Com-
plex 1 is a markedly more stable complex, as it is character-
ized by more favorable association and dissociation kinetics
compared to Complex 2.
Although binding and mutagenesis studies have shown
that Complex 1 is likely the physiologically relevant bindingFIGURE 8 Unbinding forces for C3d-Sbi-IV complexes. Steered MD
simulations were performed for each complex, in which the center of
mass of Sbi was pulled away from C3d at a rate of 10 A˚/ns, and exerted
force was reported every 20 fs. The area of the curves represents the
mean 5 SE of the force on Sbi in Complex 1 (dark gray) and Complex
2 (light gray) for five SMD trajectories.
Biophysical Journal 106(5) 1164–1173
1172 Gorham et al.mode, NMR chemical-shift perturbation experiments iden-
tified interacting residues in both binding modes (10). Inter-
estingly, none of the N-terminal residues (E201, V205, and
E209) that in previous NMR experiments were shown to
have large chemical shifts participated in persistent interac-
tions with C3d in our analysis, although V244 and L248
(which also exhibited large chemical shifts) do indeed share
persistent interactions with I1125 on C3d and contribute
significantly to the association free energy of Complex 2.
Other Sbi-IV residues deemed by our analysis to be most
critical to C3d interaction in Complex 2 (Figs. 5, B, D,
and F, and 6 C) did not show large chemical shifts. Despite
inconsistencies between our MD data and previous NMR
titration analysis data, there is better correlation between
MM-GBSA energies and NMR titration data for Complex
1 compared with Complex 2 (data not shown).
Although Sbi-IV is an AP complement inhibitor on its
own, full-length Sbi can inhibit all three pathways of com-
plement. Previous studies have shown that domains I and
II of Sbi bind immunoglobulin G molecules via their Fc
region, conferring protection of S. aureus against anti-
body-mediated opsonization, whereas domains III and IV
are involved in C3 binding (6). Recent structural analyses
were unsuccessful in determining structure of Sbi-III/IV,
and it was reported that Sbi-III has an inherently disordered
structure (10,13). Since Sbi-III/IV (and full-length Sbi)
exhibit a different mechanism of complement evasion
compared to Sbi-IV alone, it is necessary to examine our
results in light of this information.
Like Sbi-IV, Sbi-III/IV contains an interaction site on
the thioester domain of C3 and exhibits similar binding pre-
ferences for thioester-domain-containing C3 fragments
(C3d > C3 > C3b). Clark et al. suggest that the secondary
binding site of Sbi-IV on C3d (Complex 2) may represent
the binding mode when other domains of Sbi are also pre-
sent (10). Based on the observation that the N-terminus
of Sbi-IV (residues 198–205) makes strong contacts with
C3d in the crystallographic structure, the authors suggest
that the presence of Sbi-III may stabilize this weak binding
site. We observed that the N-terminus of Sbi-IV moves away
from C3d almost immediately in all MD simulations of
Complex 2, indicating that interactions of these residues
are not strong enough to keep the complex together.
In the context of structural information for C3 and C3b, it
is unlikely that Sbi-III/IV binds to C3 via the Complex 2
binding mode, as there are extensive steric clashes. The thio-
ester bond on C3d is intrinsically shielded from solvent in
native C3, precluding binding of Sbi-IV at that site unless
major conformational changes occur. In the Complex 1
site, Sbi-IV binds easily without clashes (Fig. S12 A). How-
ever, in C3b, the Complex 2 binding site appears to be the
preferred mode, as Complex 1 shows clashes with C3b
(Fig. S12 B). In addition, Sbi-III/IV binds to both C3d and
C3a in native C3, which is likely simultaneous based on
the slow biphasic association kinetics observed in surfaceBiophysical Journal 106(5) 1164–1173plasmon resonance experiments (6). Although the Sbi-IV
molecule in Complex 2 would be spatially closer to C3a
than in Complex 1, steric clashes and Sbi-IV orientation
likely preclude simultaneous binding. Through construction
of a basic homology model of Sbi-E (domains I–IV), it is
plausible that Sbi-III and Sbi-IV (in the Complex 1 binding
mode) can simultaneously bind C3a and C3d, respectively
(Fig. S12 C). Since Sbi-III/IV can form a covalent adduct
to nascent C3b (6), binding of Sbi-III/IV in an arrangement
bridging the region of C3 containing the thioester bond
would facilitate rapid transacylation upon C3 cleavage.
Although our data demonstrate much higher stability
for Complex 1 compared to Complex 2, and together with
experimental data suggest that the structure of Complex 1
is physiological, Sbi-IV alone may be capable of binding
to C3d via the Complex 2 binding mode. Despite weak in-
teractions at the termini of Sbi-IV, there is a strong central
core of polar and nonpolar interactions that remains bound
during MD simulations. We suggest that Sbi-IV can provide
a foundation for therapeutic development. C3b recognizes
and covalently attaches to both host and pathogen cell sur-
faces, and host protection is reliant on tight regulation by
other complement factors. Several autoimmune diseases
are propagated by inadequate regulation and, in turn, depo-
sition of complement on host cells. Rational structure-based
design of Sbi-IV variants may lead to novel therapeutics
targeting C3b deposition on host surfaces.SUPPORTING MATERIAL
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